
A meta-analysis of 4 randomized trials is shedding light on the efficacy and safety of direct oral anticoagulant use for reducing recurrent VTE in patients with cancer.
Patrick Campbell is the editorial director of HCPLive. Patrick has spent years spearheading coverage surrounding cardiometabolic health and rheumatic disease for MJH Life Sciences. Before joining MJH Life Sciences in 2019, he spent time as a beat reporter and/or multimedia specialist with the Pocono Record, Star News Group, and NJ Advance Media. He is the executive producer for multiple HCPLive podcasts, including Diabetes Dialogue, Don't Miss a Beat, Kidney Compass, Medical Ethics Unpacked, The Medical Sisterhood, and Skin of Color Savvy.
Follow him on Twitter @RealPatCampbell or reach him via email at [email protected].

A meta-analysis of 4 randomized trials is shedding light on the efficacy and safety of direct oral anticoagulant use for reducing recurrent VTE in patients with cancer.

An analysis of data from the UK and Canada has found no significant increase in below-knee amputations with SGLT2 inhibitor use versus DPP-4 inhibitor use.

A prespecified analysis of FOURIER is detailing the impact of evolocumab on CV events and LDL-C in patients with metabolic syndrome.

An analysis of 41 individuals with premature adrenarche or polycystic ovary syndrome revealed more than half of the patients were glucocorticoid resistant.

Results of a web-based survey indicate the rate of new type 1 diabetes diagnoses dropped nearly 25% during the early phases of the COVID-19 pandemic.

An analysis of PORTRAIT registry data indicates depression and presence of depressive symptoms can have a notable negative impact on management of peripheral artery disease.

An analysis of data from the ARIC study is detailing associations between lower levels of sex hormones and risk of incident heart failure in older adults.

New data suggests addition of HbA1c testing could improve youth diabetes screenings in the US compared to current screening standards.

A new scientific statement from the American Heart Association is acting as a "call to action" for greater research into the effects of marijuana, according to the statement's co-author.

An analysis of patient data from Europe suggests an increased number of infections requiring antibiotic use was tied to an elevated risk of coronary heart disease in type 1 diabetics.

New data shows an adherence to troponin testing could complement optimized care.

A new study is detailing the increased risk of coronary artery disease associated with certain reproductive factors in postmenopausal women.

A systematic review and meta-analysis are diving deeper into the debate over whether metformin should be prescribed to with polycystic ovary syndrome using assisted reproductive technologies, such as in vitro fertilization or intracytoplasmic sperm injection and embryo transfer.

A new analysis of a Medicare-linked database is detailing associations between loop diuretic use and nonuse after heart failure hospitalization with 30-day clinical outcomes.

Results of the VESTA trial indicate fezolinetant could one day provide a non-hormonal, oral option for reducing vasomotor menopausal symptoms and improving quality of life in postmenopausal women.

Analysis of PEGASUS-TIMI 54 patients indicates incorporating the biomarker into guideline-based risk assessment could improve risk classification and care.

Data from a prospective cohort study in Europe indicates increased antibiotic use and LPS activity levels were tied to increased incidence of coronary heart disease events.

Research suggest polycystic ovary syndrome was tied to a 19% increase in risk of cardiovascular disease in women from a cohort within the UK.

Having 3 or more pregnancies, a shorter reproductive life span, or early age at menopause onset were linked to increased risk of CAD in a recent study.

A medical researcher from the UK discusses how the ongoing pandemic has impacted diabetes research and how researchers have had to adapt during an uncertain time.

Among Hispanic and Latino patients with peripheral artery disease 31% reported use of antiplatelet therapy, 26% reported use of lipid-lowering therapy, and 57% reported use of antihypertensive therapy in a new study.

An AI-enabled ECG algorithm could speed identification and treatment of heart failure among individuals presenting with shortness of breath.

An analysis of more than 60k women suggests those with polycystic ovary syndrome were 19% more likely to develop cardiovascular disease.

Deepak Bhatt, MD, offers perspective on how the ongoing pandemic has impacted clinical trials in the cardiovascular space.

A practicing endocrinologist and professor of medicine offers insight into the potential for increase in risk of blood clots in certain groups of women if they were to contract COVID-19.

A new network meta-analysis offers an overview of the clinical benefit of less than 6 months, 6-month, 12-month, and extended periods of DAPT therapy after PCI with drug-eluting stents.

A systematic review and meta-analysis is detailing the risks of new-onset and recurrent heart failure, separately, in patients with diabetes mellitus.

Director of Yale's Pulmonary Vascular Disease Program offers insight from a recent study he led attempting to determine the root cause of blood clots in COVID-19 patients.

A practicing endocrinologist discusses his reaction to topline results from EMPEROR-REDUCED and what he hopes to see in the presentation at ESC 2020.

A systematic review and meta-analysis found bariatric surgery in obese patients was linked to decreases of more than 35% in risk of all-cause and cardiovascular mortality.